"600% Momentum-Strategie": Aktien hebeln und Gewinne maximieren - sichern Sie sich jetzt das Kennenlernangebot für nur 39 Euro (statt 69 Euro) im Monat!

NLS Pharmaceutics Aktie

Kaufen

Verkaufen

Handeln

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Bei einem anderen Broker handeln Smartphone

WKNA2P21Z

ISINCH0523961370

SymbolNLSP

NLS Pharmaceutics Aktien News

Sortieren:Datum Meistgelesen

21.05.25PR NewswireNLS Pharmaceutics to Present New Data on the Dual Efficacy of Mazindol ER in Fentanyl Reward and Withdrawal at the 2025 ASCP Annual Meeting

15.04.25PR NewswireNLS Pharmaceutics Announces Positive Results from Study KO-943 Demonstrating Mazindol Reduces Fentanyl-Induced Reward in Animal Models

10.03.25PR NewswireNLS Pharmaceutics CEO Issues Letter to Shareholders

27.02.25PR NewswireNLS Pharmaceutics Announces New Preclinical Data for AEX-2, Expanding the Therapeutic Potential of its Non-Sulfonamide Dual Orexin Receptor Agonist Platform

25.02.25PR NewswireKadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment

10.02.25PR NewswireNLS Pharmaceutics and Kadimastem Unveil Multi-Target Approach to Diabetes, Expanding Beyond GLP-1 Therapies

31.01.25PR NewswireKadimastem Shareholders Approved the Merger with NLS Pharmaceutics

30.01.25PR NewswireNLS Pharmaceutics Announces the Submission of Three Research Abstracts to the 2025 ASCP Annual Meeting

28.01.25PR NewswireNLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

16.01.25PR NewswireKadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS

08.01.25PR NewswireNLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following its Extraordinary General Meeting at a Share...

30.12.24PR NewswireNLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger

04.12.24PR NewswireNLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the Market

NLS Pharmaceutics News

NLS Pharmaceutics News: auf dieser Seite finden Sie alle NLS Pharmaceutics News und Nachrichten zur NLS Pharmaceutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch NLS Pharmaceutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um NLS Pharmaceutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.